Enzymatica AB Reports Strong Growth in Q3 2025 Amid Global Expansion Efforts Enzymatica AB's Q3 2025 report highlights significant sales growth in Sweden, with ongoing international expansion efforts and leadership changes.

Enzymatica AB Reports Strong Growth in Q3 2025 Amid Global Expansion Efforts #Sweden #Lund #ColdZyme #Enzymatica #Sana_Alajmovic

Enzymatica AB Reports Promising Q2 Growth in Sweden and Expanding Global Activities Enzymatica AB has achieved significant sales growth in Sweden during Q2 2025, while seeking international partnerships to enhance their ColdZyme product.

Enzymatica AB Reports Promising Q2 Growth in Sweden and Expanding Global Activities #Sweden #Lund #ColdZyme #Enzymatica #Claus_Egstrand

Enzymatica Reports Strong Q1 2025 Performance Amid Focus on International Growth Enzymatica's Q1 2025 report highlights impressive sales growth in Sweden and the UK, alongside plans for global expansion driven by innovative ColdZyme technology.

Enzymatica Reports Strong Q1 2025 Performance Amid Focus on International Growth #Sweden #Lund #ColdZyme #Enzymatica

Upcoming Press Briefing on ColdZyme Studies by Enzymatica AB Set for March 5, 2025 Join Enzymatica AB on March 5, 2025, for a digital press briefing revealing breakthrough results from new studies on ColdZyme, enhancing respiratory health.

Upcoming Press Briefing on ColdZyme Studies by Enzymatica AB Set for March 5, 2025 #Sweden #Stockholm #ColdZyme #Enzymatica #Research_Studies

Enzymatica AB Announces Digital Press Briefing on Groundbreaking Research Findings Enzymatica AB invites media to a digital press briefing presenting results from independent studies on ColdZyme's effects on respiratory health.

Enzymatica AB Announces Digital Press Briefing on Groundbreaking Research Findings #Sweden #Stockholm #ColdZyme #Enzymatica #Research_Studies

New Studies Reveal ColdZyme's Effectiveness Against Respiratory Infections Recent independent studies published reveal that ColdZyme significantly reduces respiratory infection symptoms and sick days, targeting the virus directly.

New Studies Reveal ColdZyme's Effectiveness Against Respiratory Infections #Sweden #Stockholm #Respiratory_Infections #ColdZyme #Enzymatica

ColdZyme Revolutionizes Cold Treatment by Addressing Infection Source, Leading to Fewer Sick Days ColdZyme's innovative approach tackles respiratory infections at their source, significantly reducing symptoms and sick days as shown in recent studies.

ColdZyme Revolutionizes Cold Treatment by Addressing Infection Source, Leading to Fewer Sick Days #USA #Stockholm #Health #Respiratory_Infections #ColdZyme

Enzymatica AB Reports Strong Year-End Performance Amid Challenges for Future Growth Enzymatica AB's year-end report reveals strong performance in core markets despite challenges, gearing up for expansive international growth in 2025.

Enzymatica AB Reports Strong Year-End Performance Amid Challenges for Future Growth #Sweden #Lund #Enzymatica_AB #ColdZyme #Lund_Sweden